First Salt After Rain Gray Salt Toothpaste
FDA Label NDC 83876-010

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Imjacompany.co for the product First Salt After Rain Gray Salt Toothpaste (NDC 83876-010). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, inactive ingredients, purpose, warnings, keep out of reach of children, uses, directions, other information, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Active Ingredient

CALCIUM CARBONATE 38.0%

Inactive Ingredients

Sorbitol, Water, Glycerin, Sodium Lauryl Sulfate, PEG-32, Cellulose Gum, Sodium Saccharin, Mentha Piperita Oil, Silica, Titanium Dioxide, Sodium Benzoate, Sodium Chloride, Dicalcium Phosphate Dihydrate, Menthol, 6-Aminocaproic Acid, Alcloxa, Xylitol, Ascorbic Acid

Purpose

Anti-carries

Warnings

Keep out of the reach of children under 6 years of age.

If more than used for brushing is accidentally swallowed, get medical help or contact a Poison Control Center right away.

Keep Out Of Reach Of Children

Keep out of the reach of children under 6 years of age.

Uses

helps protect against cavities.

Directions

■ adults and children 2 years of age and older : brush teeth thoroughly, preferably after each meal or at least twice a day, or as directed by a dentist or physician
■ children 2 to 6 years : use only a pea sized amount and supervise child's brushing and rinsing (to minimize swallowing)
■ children under 2 years : ask a dentist or physician

Other Information

Do not store this product in an inappropriate place such as high or low temperatures or under direct sun light.

Questions

https://firstsalt.kr
+82 80-262-3800

* Please review the disclaimer below.